… non–small cell lung cancer (NSCLC) treatment focusing on vaccine approaches to elicit
specific immune responses and development of inhibitors of the molecular mediators of cancer-…

… Lung cancer is the leading cause of cancer death worldwide. Majority of newly diagnosed
lung cancers are non-small cell lung cancer (… population, making management for these …

… and tumor factors that are predictive of survival for patients with non-small cell lung cancer
(… factors relevant to patients with lung cancer receiving radiation therapy with curative intent. …

… part of the treatment of lung cancer has expanded significantly, … For advanced stage non-small
cell lung cancer (NSCLC), … are now the standard of care in patients with advanced stage …

Background Among patients with non–small-cell lung cancer (NSCLC), data on intratumor
heterogeneity and cancer genome evolution have been limited to small retrospective cohorts. …

… underlie lung cancer development and possible treatments in the past decade present the
opportunity to integrate information from multiple approaches for future lung cancer treatment. …

… A review of the management of elderly patients with non-small-cell lung cancer.  … A
review of the management of elderly patients with non-small-cell lung …

… -recommended treatment was assessed for 20,511 veterans age ≥ 65 years with non–small-cell
lung cancer (NSCLC) in the Veterans Affairs (VA) Central Cancer Registry from 2003 to …

… At the outset of this meta- analysis there wasconsiderable pessimism about the treatment
of non-small cell lung cancer. Although the observed effects are modest, these results offer …

… The pathological diagnosis of non-small cell lung cancer (NSCLC) … Lung Cancer (IASLC)
provided adenocarcinoma classification as well as key recommendations for the management …